We found that the expression of epithelial marker E-cadherin was downregulated, while the expression of mesenchymal markers, including ZEB-1, Vimentin, Slug and α-SMA, were upregulated, indicating the enhanced EMT in tumor issuses pretreated with ISO (Fig. 1E and F). The gene discussed is ACTA1; the disease is neoplasm.